Literature DB >> 9889225

Detection of rubella virus-specific immunoglobulin G in saliva by an amplification-based enzyme-linked immunosorbent assay using monoclonal antibody to fluorescein isothiocyanate.

A J Vyse1, D W Brown, B J Cohen, R Samuel, D J Nokes.   

Abstract

An immunoglobulin G (IgG)-capture enzyme-linked immunosorbent assay (ELISA) for rubella virus is described. The assay uses a fluorescein isothiocyanate (FITC)-anti-FITC amplification system. The detection limit of the ELISA was approximately 7 IU of rubella virus-specific IgG per ml of serum sample. For saliva samples the performances of the capture ELISA and previously described radioimmunoassay were assessed, and the results of those two assays were compared to the rubella virus-specific IgG result obtained by a commercial ELISA (Behring Enzygnost) with a panel of paired serum and saliva samples. This comparison showed that the capture ELISA with saliva was more sensitive than the radioimmunoassay and that the results correlated better with the serum IgG result than the results of the radioimmunoassay did, with an overall sensitivity of 82% and a rank correlation of 0.68, whereas the sensitivity and rank correlation for the radioimmunoassay were 74% and 0.45, respectively. For subjects of 10 years of age or younger, the ELISA with saliva had a sensitivity of 94% and a specificity of 100% compared to the results of the ELISA (Behring Enzygnost) for rubella virus-specific IgG with corresponding serum samples. The sensitivity was much lower for subjects ages 17 years or older. The assay may have wider epidemiological use with saliva specimens, particularly those from children.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9889225      PMCID: PMC84317          DOI: 10.1128/JCM.37.2.391-395.1999

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

Review 1.  Laboratory diagnosis of rubella: past, present and future.

Authors:  J E Cradock-Watson
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

2.  A sensitive method of detecting proteins on dot and Western blots using a monoclonal antibody to FITC.

Authors:  D Samuel; R J Patt; R A Abuknesha
Journal:  J Immunol Methods       Date:  1988-03-16       Impact factor: 2.303

3.  Prevalence of measles antibody among children under 15 years of age in Santa Cruz, Bolivia: implications for vaccination strategies.

Authors:  F T Cutts; A Bartoloni; P Guglielmetti; F Gil; D Brown; M L Bianchi Bandinelli; M Roselli
Journal:  Trans R Soc Trop Med Hyg       Date:  1995 Jan-Feb       Impact factor: 2.184

Review 4.  Simple and reliable salivary tests for HIV and hepatitis A and B virus diagnosis and surveillance.

Authors:  J V Parry
Journal:  Ann N Y Acad Sci       Date:  1993-09-20       Impact factor: 5.691

5.  Comparison of four enzyme immunoassays for detection of immunoglobulin M antibodies against rubella virus.

Authors:  L Matter; M Gorgievski-Hrisoho; D Germann
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

6.  The isolation of IgG from mammalian sera with the aid of caprylic acid.

Authors:  M Steinbuch; R Audran
Journal:  Arch Biochem Biophys       Date:  1969-11       Impact factor: 4.013

7.  The production of monoclonal antibodies to rubella haemagglutinin and their use in antibody-capture assays for rubella-specific IgM.

Authors:  R S Tedder; J L Yao; M J Anderson
Journal:  J Hyg (Lond)       Date:  1982-04

8.  Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3.

Authors:  D W Brown; M E Ramsay; A F Richards; E Miller
Journal:  BMJ       Date:  1994-04-16

9.  Salivary antibody detection in epidemiological surveys: a pilot study after a mass vaccination campaign against rubella in São Paulo, Brazil.

Authors:  R S de Azevedo Neto; A Richards; D J Nokes; A S Silveira; B J Cohen; S D Passos; V A de Souza; D W Brown; C S Pannuti; E Massad
Journal:  Trans R Soc Trop Med Hyg       Date:  1995 Jan-Feb       Impact factor: 2.184

10.  Rubella surveillance to June 1994: third joint report from the PHLS and the National Congenital Rubella Surveillance Programme.

Authors:  E Miller; P Tookey; P Morgan-Capner; L Hesketh; D Brown; P Waight; J Vurdien; G Jones; C Peckham
Journal:  Commun Dis Rep CDR Rev       Date:  1994-11-11
View more
  7 in total

1.  Application of a noninvasive oral fluid test for detection of treponemal IgG in a predominantly HIV-infected population.

Authors:  P A C Maple; I Simms; G Kafatos; M Solomou; K Fenton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-12       Impact factor: 3.267

2.  Diagnosis of norwalk virus infection by indirect enzyme immunoassay detection of salivary antibodies to recombinant norwalk virus antigen.

Authors:  Christine L Moe; Arnie Sair; Lisa Lindesmith; Mary K Estes; Lee-Ann Jaykus
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

3.  Enzyme-linked immunosorbent assay using recombinant SAG1 antigen to detect Toxoplasma gondii-specific immunoglobulin G antibodies in human sera and saliva.

Authors:  Nouha Chahed Bel-Ochi; Aïda Bouratbine; Mohamed Mousli
Journal:  Clin Vaccine Immunol       Date:  2013-01-23

4.  Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models.

Authors:  E O Ohuma; E A Okiro; A Bett; J Abwao; S Were; D Samuel; A Vyse; N Gay; D W G Brown; D J Nokes
Journal:  Epidemiol Infect       Date:  2008-06-10       Impact factor: 2.451

5.  Detection of low-avidity immunoglobulin G in oral fluid samples: new approach for rubella diagnosis and surveillance.

Authors:  D Akingbade; B J Cohen; D W G Brown
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

Review 6.  Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs.

Authors:  Peter A C Maple
Journal:  Vaccines (Basel)       Date:  2015-12-09

7.  Oral fluid testing during 10 years of rubella elimination, England and Wales.

Authors:  Gayatri Manikkavasagan; Antoaneta Bukasa; Kevin E Brown; Bernard J Cohen; Mary E Ramsay
Journal:  Emerg Infect Dis       Date:  2010-10       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.